High-dose-rate brachytherapy in early oral cancer with close or positive margins

The HDR BT 18 × 3 Gy b.i.d. is a safe treatment of early oral cancer with a good LC. The T-stage, tumor grade, depth of invasion, and intensity of VEGF were significant predictors of locoregional control.